John Libbey Eurotext

European Journal of Dermatology


Use of anti-IL 17A for psoriasis is not necessarily contraindicated in organ transplantation patients Volume 30, numéro 3, May-June 2020


  • Figure 1
1 Department of Experimental, Diagnostic and Specialty Medicine- Division of Dermatology, University of Bologna, Bologna, Italy
2 Department of Transplant and Organ Failure, University of Bologna, Bologna, Italy

The advent of biologic agents has revolutionized the management of psoriasis, but there is a dearth of literature on patients with organ transplants because of the risk of over-immunosuppression [1]. We report the successful treatment of severe plaque psoriasis with ixekizumab in a patient who underwent kidney transplantation.A 35-year-old man with a 14-year history of plaque psoriasis presented with a severe flare of the disease. The patient had a family history of psoriasis and suffered from Crohn's [...]